Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

ATP, Mg2+, Nuclear Phase Separation, and Genome Accessibility.

Wright RHG, Le Dily F, Beato M.

Trends Biochem Sci. 2019 May 6. pii: S0968-0004(19)30053-2. doi: 10.1016/j.tibs.2019.03.001. [Epub ahead of print] Review.

2.

Hormone-control regions mediate steroid receptor-dependent genome organization.

Le Dily F, Vidal E, Cuartero Y, Quilez J, Nacht AS, Vicent GP, Carbonell-Caballero J, Sharma P, Villanueva-Cañas JL, Ferrari R, De Llobet LI, Verde G, Wright RHG, Beato M.

Genome Res. 2019 Jan;29(1):29-39. doi: 10.1101/gr.243824.118. Epub 2018 Dec 14.

PMID:
30552103
3.

Arginine Citrullination at the C-Terminal Domain Controls RNA Polymerase II Transcription.

Sharma P, Lioutas A, Fernandez-Fuentes N, Quilez J, Carbonell-Caballero J, Wright RHG, Di Vona C, Le Dily F, Schüller R, Eick D, Oliva B, Beato M.

Mol Cell. 2019 Jan 3;73(1):84-96.e7. doi: 10.1016/j.molcel.2018.10.016. Epub 2018 Nov 21.

PMID:
30472187
4.

Unliganded Progesterone Receptor Governs Estrogen Receptor Gene Expression by Regulating DNA Methylation in Breast Cancer Cells.

Verde G, De Llobet LI, Wright RHG, Quilez J, Peiró S, Le Dily F, Beato M.

Cancers (Basel). 2018 Oct 5;10(10). pii: E371. doi: 10.3390/cancers10100371.

5.

Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells.

Page BDG, Valerie NCK, Wright RHG, Wallner O, Isaksson R, Carter M, Rudd SG, Loseva O, Jemth AS, Almlöf I, Font-Mateu J, Llona-Minguez S, Baranczewski P, Jeppsson F, Homan E, Almqvist H, Axelsson H, Regmi S, Gustavsson AL, Lundbäck T, Scobie M, Strömberg K, Stenmark P, Beato M, Helleday T.

Nat Commun. 2018 Jan 17;9(1):250. doi: 10.1038/s41467-017-02293-7.

6.

Insight into the machinery that oils chromatin dynamics.

Wright RH, Fernandez-Fuentes N, Oliva B, Beato M.

Nucleus. 2016 Nov;7(6):532-539. doi: 10.1080/19491034.2016.1255392. Epub 2016 Nov 28. Review.

7.

ADP-ribose-derived nuclear ATP synthesis by NUDIX5 is required for chromatin remodeling.

Wright RH, Lioutas A, Le Dily F, Soronellas D, Pohl A, Bonet J, Nacht AS, Samino S, Font-Mateu J, Vicent GP, Wierer M, Trabado MA, Schelhorn C, Carolis C, Macias MJ, Yanes O, Oliva B, Beato M.

Science. 2016 Jun 3;352(6290):1221-5. doi: 10.1126/science.aad9335.

8.

Distinct structural transitions of chromatin topological domains correlate with coordinated hormone-induced gene regulation.

Le Dily F, Baù D, Pohl A, Vicent GP, Serra F, Soronellas D, Castellano G, Wright RH, Ballare C, Filion G, Marti-Renom MA, Beato M.

Genes Dev. 2014 Oct 1;28(19):2151-62. doi: 10.1101/gad.241422.114.

9.

PARty promoters: hormone-dependent gene regulation requires CDK2 activation of PARP1.

Wright RH, Beato M.

Cell Cycle. 2012 Dec 1;11(23):4291-3. doi: 10.4161/cc.22531. Epub 2012 Oct 24.

10.

CDK2-dependent activation of PARP-1 is required for hormonal gene regulation in breast cancer cells.

Wright RH, Castellano G, Bonet J, Le Dily F, Font-Mateu J, Ballaré C, Nacht AS, Soronellas D, Oliva B, Beato M.

Genes Dev. 2012 Sep 1;26(17):1972-83. doi: 10.1101/gad.193193.112.

11.

TopBP1 contains a transcriptional activation domain suppressed by two adjacent BRCT domains.

Wright RH, Dornan ES, Donaldson MM, Morgan IM.

Biochem J. 2006 Dec 15;400(3):573-82.

Supplemental Content

Loading ...
Support Center